NASDAQ: AGPUAxe Compute Inc Stock
$1.95+0.16 (+8.94%)
Updated Mar 13, 2026
AGPU Price
$1.95
Fair Value Price
N/A
Market Cap
$6.62M
52 Week Low
$1.65
52 Week High
$39.00
P/E
-0.02x
P/B
-0.09x
P/S
14.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$728.20k
Earnings
-$84.33M
Gross Margin
50.2%
Operating Margin
-11,581.34%
Profit Margin
-11,581.3%
Debt to Equity
-1.04
Operating Cash Flow
-$8M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
AGPU Overview
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AGPU's potential to beat the market
- AGPU doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
AGPU
RankedUnranked of 41
RankedUnranked of 41
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.31 | A | |
| $8.79 | A | |
| $24.61 | A |
Be the first to know about important AGPU news, forecast changes, insider trades & much more!
AGPU News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AGPU scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AGPU is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AGPU is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
AGPU's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more AGPU due diligence checks available for Premium users.
Valuation
AGPU fair value
Fair Value of AGPU stock based on Discounted Cash Flow (DCF)
Price
$1.95
Fair Value
-$6.39
Undervalued by
130.53%
AGPU is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
AGPU price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.02x
Industry
-410.01x
Market
31.82x
AGPU price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.09x
Industry
3.4x
AGPU's financial health
Profit margin
Revenue
$3.6k
Net Income
-$77.7M
Profit Margin
-2,146,264.3%
AGPU's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AGPU's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.1M
Liabilities
$80.6M
Debt to equity
-1.04
AGPU's short-term liabilities ($79.49M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AGPU's short-term assets ($1.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AGPU's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AGPU's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.7M
Investing
$0.0
Financing
$1.3M
AGPU's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
AGPU vs Medical Stocks
Axe Compute Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.